Shandong Nstmi New Materials Co., Ltd. (hereinafter referred to as Nstmi New Materials) is committed to being a high-quality service provider in the transdermal drug delivery industry. Its main products, styrene isoprene styrene block copolymer (SIS) and drug auxiliary methyl acrylate/2-ethylhexyl acrylate copolymer emulsion, have completed the CDE filing with the China Food and Drug Administration. It is the only production-oriented enterprise in China that replaces the original research import filing. The development and industrialization project of hot melt pressure-sensitive adhesive based medical materials launched by the company in 2024 has been selected as a major scientific and technological innovation project in Shandong Province.




















